COVID 19 Update and Other Brief Bits

Doc Gumshoe on progress with Hydroxychloroquine, Remdesivir and other potential treatments... plus updates on heartburn treatments and Parkinson's Disease

By Michael Jorrin, "Doc Gumshoe", April 20, 2020

It’s hard to stay away from the coronavirus pandemic, even though Doc Gumshoe basically has no information that’s any different from what’s flooding into your inboxes or TV screens or, for those of us who are still members of the ancient fellowship of newspaper readers, the pages of our daily newspapers.   But a few topics demand some Gumshoe-like sleuthing.

Can hydroxychloroquine combat the coronavirus?

The possibility that hydroxychloroquine may deliver at least some benefit to individuals infected with the coronavirus needs to be examined carefully.   From some quarters comes unquestioning approval – it’s the best possible news about COVID 19, and the call is for all hands to put this near-miracle to work saving huge numbers of innocent lives.   And from other quarters, diametrically opposed views are being expressed – hydroxychloroquine, along with chloroquine, has not been shown to be effective, and giving patients large doses of this drug will do nothing but put their lives at risk. 

Hydroxychloroquine (HCQ), trade-named Plaquenil, from Mylan (MYL), is widely used as an antimalarial drug, although some malaria pathogens have developed resistance to HCQ.   It is also used to treat systemic lupus and, in some cases, rheumatoid arthritis.   And it is also one of the very few drugs that are at least partially effective against Sjögren’s syndrome. 

A clinical trial in Wuhan, China reported evidence of benefit in some patients with COVID 19 treated with HCQ.   A total of 62 patients hospitalized with COVID 19 were randomized to receive what was considered standard treatment, or standard treatment plus 400 mg HCQ tablets for five days.   Standard treatment included oxygen therapy, antiviral and antibacterial drugs, and immunoglobulin.    The primary endpoint was time to clinical recovery, which was defined as a return to normal body temperature and cough relief, maintained for more than 72 hours.

The patients in the group receiving HCQ experienced a shorter time to return to normal body temperature than controls – 2.2 days in the cohort receiving HCQ versus 3.2 days for controls.   Time to cough relief was also shorter in the HCQ cohort – 2.0 days versus 3.1 days.   Both outcomes were considered to be highly significant – P = 0.0008 for return to normal body temperature and P = 0.0016 for cough relief.

Four of the 62 patients, all in the control group, progressed to severe illness.   Overall, a larger proportion of patients receiving HCQ experienced improvement in pneumonia symptoms compared with those in the control group – 80.6% versus 54.8%.

In the meantime, there has been considerable public controversy about HCQ in the treatment of COVID 19.   For example, a primary care physician in the New York suburbs has been using HCQ as part of a three-drug cocktail for patients infected with the virus, the other two drugs being the antibiotic azithromycin and zinc sulfate, which is thought (by some) to bolster immune response.   This physician, Dr Vladimir Zelenko, has treated hundreds of patients with COVID 19, mostly in a community of 35,000 Hasidic Jews called Kiryas Joel.

Dr Zelenko has claimed that 100% of the patients that he treated with this combination had survived the virus with no hospitalizations and no need for a ventilator.   His claims have been taken up and disseminated by a number of prominent figures, including Sean Hannity, the Fox News personality; also by Mark Meadows, who is the incoming White House Chief of Staff.   The notorious Rudy Giuliani lavished praise on Dr Zelenko for “thinking of solutions, just like the President,” and posted a tweet calling HCQ “100% effective in treating COVID 19.”   And the president of Brazil, Jair Bolsonaro, has stated that HCQ is a definite “cure” for COVID 19.

President Trump has been highly enthusiastic about HCQ.   For weeks he has been claiming that it is “very effective,” and perhaps the “biggest game changer in the history of medicine.”   The president has had public run-ins with Dr Anthony S. Fauci, head of the National Institute of Allergy and Infectious Diseases.   In a television appearance, after Mr Trump once again evinced a high degree of confidence in HCQ, a reporter turned to Dr Fauci and asked him what he though